Bristol-Myers Squibb - Corporate Responsibility - Grants Submission Process


	Patient Assistance Programs
	Fighting AIDS in Africa
	Bristol-Myers Squibb Foundation & Corporate Philanthropy
	Product Integrity
	Sustainability: Our Plan for Responsible Growth
	Environment, Health & Safety Policy
	Medical Education Grants And Charitable Contributions
	Clinical Outcomes And Research Grants
	Position On Key Issues

» BMS.com Home » Corporate Responsibility » Grants Submission Process - Coming Soon

Canada:
BMS Canada
Grant Administrator
2365 Cote-de-Liesse
Montreal, Quebec, Canada
H4N 2M7

South American and Latin America:
Brazil: maria-luiza.passeti@bms.com
Mexico: haydee.chavez@bms.com
Puerto Rico: irma.cruz@bms.com
Argentina: diana.umerez@bms.com
Colombia: liliana.tascon@bms.com
Ecuador: silvia.garcia@bms.com
Peru/Chile: annemarie.funcke@bms.com
Venezuela: celeste.avendano@bms.com

Europe, Africa and Middle East:
fabiana.funari@bms.com

Japan:
Coming Soon

AsiaPac:
jenny.stephenson@bms.com

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.